Nicaragua vs South-East Asia (WHO region): Treatment success rate: XDR-TB cases
Nicaragua
100
in 2021
South-East Asia (WHO region)
73
in 2022
Nicaragua rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate: XDR-TB cases over time
- Nicaragua
- South-East Asia (WHO region)
How they compare
Nicaragua currently reports 100 against 73 in South-East Asia (WHO region), a difference of 27.
That makes Nicaragua's figure about 1.4 times South-East Asia (WHO region)'s.
The two have swapped places 2 times across 5 shared years of data; in 2015 it was Nicaragua ahead.
Nicaragua ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
Across the 2 decades both report, Nicaragua averaged higher in 1 and South-East Asia (WHO region) in 1.
Head to head by decade
| Decade | Nicaragua | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 35.67 | 64.33 | Nicaragua |
| 2020s | 50 | 67 | 17 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Nicaragua or South-East Asia (WHO region)?
- Nicaragua, at 100 against 73 in South-East Asia (WHO region) as of 2021.
- What is the difference in treatment success rate: xdr-tb cases between Nicaragua and South-East Asia (WHO region)?
- 27, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and South-East Asia (WHO region)?
- 5 years are reported by both, from 2015 to 2021.
- How do Nicaragua and South-East Asia (WHO region) rank globally for treatment success rate: xdr-tb cases?
- Nicaragua ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.